Andrew reviews his public scorecard, Matt surveys the macro landscape and Claude talks about the perils (and opportunities) of investing in micro-caps.
Andrew reviews his public scorecard, Matt surveys the macro landscape and Claude talks about the perils (and opportunities) of investing in micro-caps.
We recently caught up with Dalrymple Bay Infrastructure (ASX:DBI) CEO Michael Riches. The conversation reminded me of a neat little rule of thumb for valuing dividend stocks. If you’re someone who likes your dividends, it’s a handy addition to your investing tool kit. It’s called the Gordon Growth Model, and the simple version tells us that a stock’s total expected return is […]
Between 2019 and 2020 Warren Buffett’s Berkshire Hathaway (NYSE:BRK) underperformed the S&P500 by 37%. It was one of the poorer periods of relative performance for the Oracle of Omaha, who was “burdened” with loads of cash and missed out on a lot of the boom in technology stocks. As you can see, Buffett regularly lags the broader index. And sometimes […]
There’s a growing sense of discontent today, and not unreasonably so for those who feel the system has let them down. And, let’s be real, it has let a great many people down. Unless you have outsized earning power, or have built up a decent portfolio of assets, life is getting increasingly difficult. And even if you do, life isn’t […]
Ben Hunt, former hedge fund manager and creator of Epsilon Theory, once wrote that a bet is a tax on bullshit. It is a sharp and accurate reminder that opinions are free, narratives are endless and forecasts cost nothing to produce. Talk demands nothing. A bet, however, demands everything. It requires sacrifice. It forces you to risk something you value […]
Medical imaging software provider Volpara (ASX:VHT) has delivered another set of strong results today, reporting financial results for the six months ending 30 September, 2019. Total revenue surged 197% to NZ$6.8 million, with subscription revenue up 148% to NZ$5.2 million. At the end of the period, Volpara’s level of annual recurring revenue was NZ$15.7 million, up from just NZ$4.8 million […]
A lot of investors seem to be pivoting their investment strategies in light of the coronavirus crisis. Mine, for better or worse, remains essentially unchanged: Seek to acquire a range of quality companies with a view to holding them for many years. Aim to hold between 10-15 companies that do not have highly correlated risks. A quality company is one […]
The Aussie market, as measured by the S&P All Ordinaries Index, entered a ‘technical correction’ this week, having fallen more than 10% from the record high it hit at the start of the year. Small cap stocks have fared worse, down about 14% over the same period of time according the ASX Small Ords. The situation for tech investors is […]